Phase 1 Parkinson Disease trials recruiting now

All Parkinson Disease trials, every phase

Other phases for Parkinson Disease

Phase 1 Parkinson Disease trials

• A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease
  NCT07543861 · Phase: Phase 1 · Ages: 50 Years and older · Sex: All (male and female) · 1 location
• A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
  NCT06809400 · Phase: Phase 1 · Ages: 30 Years to 85 Years · Sex: All (male and female) · 14 locations
• A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)
  NCT07513441 · Phase: Phase 1 · Ages: 35 Years to 85 Years · Sex: All (male and female) · 4 locations
• A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR201 in the Treatment of Subjects With Parkinson's Disease
  NCT06978920 · Phase: Phase 1 · Ages: 40 Years to 75 Years · Sex: All (male and female) · 1 location
• A Two-Part Single and Multiple Ascending Dose Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LBT-3627 in Healthy Participants and in Participants With Parkinson's Disease.
  NCT06466525 · Phase: Phase 1 · Ages: 30 Years to 89 Years · Sex: All (male and female) · 2 locations
• Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients
  NCT07371338 · Phase: Phase 1 · Ages: 50 Years to 80 Years · Sex: All (male and female) · 1 location
• Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
  NCT07154511 · Phase: Phase 1, Phase 2 · Ages: 45 Years and older · Sex: All (male and female) · 1 location
• Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosomes for Parkinson's Disease
  NCT05152394 · Phase: Phase 1 · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GT-02287 in Parkinson's Disease
  NCT06732180 · Phase: Phase 1 · Ages: 30 Years to 85 Years · Sex: All (male and female) · 7 locations
• Tenofovir Disoproxil Fumarate in the Treatment of Parkinson's Disease
  NCT06356662 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• The Safety, Tolerability and Efficacy of NouvNeu001 for Parkinson's Disease
  NCT06167681 · Phase: Phase 1, Phase 2 · Ages: 50 Years to 75 Years · Sex: All (male and female) · 2 locations
• The University of Alabama at Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
  NCT03457493 · Phase: Phase 1, Phase 2 · Ages: 30 Years and older · Sex: All (male and female) · 1 location
• This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.
  NCT07102342 · Phase: Phase 1, Phase 2 · Ages: 30 Years to 75 Years · Sex: All (male and female) · 1 location
• Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons
  NCT06687837 · Phase: Phase 1 · Ages: 45 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.